Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC11667 | PF-592379 | A potent, selective, orally active agonist of dopamine D3 receptor with EC50 of 21 nM. |
![]() |
DC8799 | Avanafil(TA-1790) Featured | Avanafil(TA-1790) is a potent and highly selective phosphodiesterase-5(PDE-5) inhibitor(IC50=5.2 nM) for erectile dysfunction; lower selectivity against PDE1, PDE6, and PDE11. |
![]() |
DC8177 | Enclomiphene citrate Featured | Enclomiphene is a non-steroidal estrogen receptor antagonist that promotes gonadotropin-dependent testosterone secretion by the testes. |
![]() |
DC11664 | PF-00446687 hydrochloride | PF-00446687 hydrochloride (PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM. |
![]() |
DC11665 | PF-00446687 | PF-00446687(PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM. |
![]() |
DC7480 | PF-3274167(cligosiban) Featured | PF-3274167 is a high-affinity nonpeptide oxytocin receptor (OTR) antagonist, with Ki of 9.5 nM. |
![]() |
DC5901 | Tadalafil Featured | Tadalafil is a potent and selective inhibitor of Phosphodiesterase-5 (PDE5) This compound prevents the breakdown of phosphodiesterases, many of which are used as secondary messengers. By preventing the breakdown of these messenger molecules, tadalafil can |
![]() |
DC4133 | Udenafil | Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED) |
![]() |